Other (17)
- ANALYTE_TYPE - Analyte Type (phv00400280.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00400279.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00400271.v1.p1)
- Funding_Source - Project funding source (phv00400283.v1.p1)
- IS_TUMOR - Whether or not sample came from a tumor tissue (phv00400281.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00400278.v1.p1)
- SAMPLE_ID - Sample ID (phv00400277.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00400282.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used at the source repository (phv00400273.v1.p1)
- SOURCE_SUBJECT_ID2 - Subject ID used in the SUBJECT_SOURCE2 repository (phv00400275.v1.p1)
- Study_Name - TOPMed Project that funded sequencing (phv00400285.v1.p1)
- SUBJECT_ID - Subject ID (phv00400270.v1.p1)
- SUBJECT_ID - Subject ID (phv00400276.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00400272.v1.p1)
- SUBJECT_SOURCE2 - Repository name for dbGaP study also containing this individual (phv00400274.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00400284.v1.p1)
- TOPMed_Project - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00400286.v1.p1)